ARROW ALEXANDER K. (Chief Financial Officer) purchased 1.7% of their position (2K shares) of PROTAGENIC THERAPEUTICS, INC.\NEW on the open market
Open‑market purchase worth $4.6K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 5/3/2021ACC: 0001493152-21-010335
Officer· Chief Financial Officer
Since Mar 2019
+2K
Net shares
Net buyer
$4.6K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
2K acquired
Non-Derivative Transactions2
PTIX Common Stock
Direct
Shares
+1K
Price / share
$2.29
Trade value
$2.29K
% of position
0.8%
4/29/2021
118.26K→119.26K
PTIX Common Stock
Direct
Shares
+1K
Price / share
$2.29
Trade value
$2.29K
% of position
0.8%
4/30/2021
119.26K→120.26K
Total
Net shares
+2K
Net value
$4.58K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| PTIX Common Stock Direct | 4/29/2021 | P · Purchase | +1K | $2.29 | $2.29K | 0.8% | 118.26K | 119.26K |
| PTIX Common Stock Direct | 4/30/2021 | P · Purchase | +1K | $2.29 | $2.29K | 0.8% | 119.26K | 120.26K |
| Total | +2K | $4.58K | ||||||
Derivative Transactions0
No derivative transactions reported